Open main menu

Pages with the most revisions

Showing below up to 500 results in range #1 to #500.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. ICRP Glossary‏‎ (267 revisions)
  2. Application of ionising radiation in healthcare‏‎ (98 revisions)
  3. Information for healthcare providers‏‎ (80 revisions)
  4. Information for patients, family members, carers and the public‏‎ (62 revisions)
  5. System Of Radiation Protection Overview‏‎ (43 revisions)
  6. Guide to Radiological Protection in Healthcare‏‎ (43 revisions)
  7. General Information on Radon‏‎ (31 revisions)
  8. Main Page‏‎ (29 revisions)
  9. Application of ionising radiation in healthcare (old)‏‎ (24 revisions)
  10. Information for healthcare providers (old)‏‎ (24 revisions)
  11. Information for patients, family members, carers and the public (old)‏‎ (24 revisions)
  12. Effective dose‏‎ (23 revisions)
  13. Radon For Governments and Employers‏‎ (23 revisions)
  14. Radon For Homeowners and Residents‏‎ (22 revisions)
  15. The System of Radiological Protection‏‎ (21 revisions)
  16. Guide to Radon‏‎ (19 revisions)
  17. Tissue weighting factor‏‎ (17 revisions)
  18. List of ICRP Publications on Radiological Protection in Healthcare‏‎ (16 revisions)
  19. ICRP publications‏‎ (14 revisions)
  20. System of radiation protection module 2‏‎ (14 revisions)
  21. Quotes from Publications on the System of Radiological Protection‏‎ (13 revisions)
  22. Equivalent dose‏‎ (11 revisions)
  23. Absorbed, Equivalent, and Effective Dose‏‎ (10 revisions)
  24. Objectives of Radiological Protection‏‎ (9 revisions)
  25. Air-kerma rate constant‏‎ (9 revisions)
  26. Fundamental Principles of Radiological Protection‏‎ (9 revisions)
  27. Absorbed dose‏‎ (9 revisions)
  28. Effects of Exposure‏‎ (8 revisions)
  29. Prudence‏‎ (8 revisions)
  30. Beneficence‏‎ (8 revisions)
  31. Organ/tissue absorbed dose‏‎ (8 revisions)
  32. Collective effective dose‏‎ (7 revisions)
  33. Linear energy transfer‏‎ (6 revisions)
  34. Accelerated fractionation‏‎ (6 revisions)
  35. Exposure Categories and Situations‏‎ (6 revisions)
  36. Investigation level‏‎ (6 revisions)
  37. Alimentary tract‏‎ (6 revisions)
  38. ICRPædia Guides‏‎ (6 revisions)
  39. Justice‏‎ (6 revisions)
  40. Justification‏‎ (5 revisions)
  41. Kerma‏‎ (5 revisions)
  42. Protection quantities‏‎ (5 revisions)
  43. Types of materials‏‎ (5 revisions)
  44. Radiation weighting factor‏‎ (5 revisions)
  45. Air-kerma, entrance surface‏‎ (5 revisions)
  46. Sources of Radiation Exposure‏‎ (5 revisions)
  47. Dose coefficient‏‎ (5 revisions)
  48. Quality factor‏‎ (5 revisions)
  49. Principle of optimisation‏‎ (5 revisions)
  50. ICRPædia Guide to the System of Radiological Protection‏‎ (5 revisions)
  51. Absorbed fraction‏‎ (5 revisions)
  52. Effective half-life‏‎ (4 revisions)
  53. Averted dose‏‎ (4 revisions)
  54. Kp index‏‎ (4 revisions)
  55. Protective action‏‎ (4 revisions)
  56. Reference Animal and Plant‏‎ (4 revisions)
  57. Source-related assessment‏‎ (4 revisions)
  58. Forbiddenness‏‎ (4 revisions)
  59. Aerodynamic diameter‏‎ (4 revisions)
  60. ICRP‏‎ (4 revisions)
  61. Diagnostic reference level‏‎ (4 revisions)
  62. Risk‏‎ (4 revisions)
  63. Senescence‏‎ (4 revisions)
  64. Reference bioassay function‏‎ (4 revisions)
  65. Air-kerma, product‏‎ (4 revisions)
  66. Fractionation sensitivity‏‎ (4 revisions)
  67. Optimisation‏‎ (4 revisions)
  68. Sievert‏‎ (4 revisions)
  69. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  70. S coefficient (radiation weighted)‏‎ (4 revisions)
  71. Non-maleficence‏‎ (4 revisions)
  72. High linear energy transfer radiation‏‎ (4 revisions)
  73. Direct bioassay‏‎ (4 revisions - redirect page)
  74. Bioassay‏‎ (4 revisions)
  75. Calculating Radon Doses‏‎ (4 revisions)
  76. Computed tomography dose index‏‎ (4 revisions)
  77. Mass median diameter‏‎ (4 revisions)
  78. Alpha decay‏‎ (4 revisions)
  79. Effective charge number‏‎ (4 revisions)
  80. Math‏‎ (4 revisions)
  81. Programmed cell death‏‎ (4 revisions)
  82. Dose equivalent‏‎ (3 revisions)
  83. Field-size effect (Volume effect)‏‎ (3 revisions)
  84. Gastrointestinal syndrome‏‎ (3 revisions)
  85. Wisdom‏‎ (3 revisions)
  86. Biomedical research volunteer‏‎ (3 revisions)
  87. Cardiomyopathy‏‎ (3 revisions)
  88. Dose limit‏‎ (3 revisions)
  89. Target region‏‎ (3 revisions)
  90. Flexible tissues‏‎ (3 revisions)
  91. Guide to the System of Radiological Protection‏‎ (3 revisions)
  92. Autonomy‏‎ (3 revisions)
  93. Dose‏‎ (3 revisions)
  94. Dose limits‏‎ (3 revisions)
  95. Fluence‏‎ (3 revisions)
  96. Constancy test‏‎ (3 revisions)
  97. DS02‏‎ (3 revisions)
  98. Fluoroscopically guided interventions‏‎ (3 revisions)
  99. Annual dose‏‎ (3 revisions)
  100. Potential exposure‏‎ (3 revisions)
  101. Rigidity threshold‏‎ (3 revisions)
  102. Dose of record (E)‏‎ (3 revisions)
  103. Low Earth orbit‏‎ (3 revisions)
  104. Accountability‏‎ (3 revisions)
  105. X ray‏‎ (3 revisions)
  106. Half-life, physical‏‎ (3 revisions)
  107. Cell death‏‎ (3 revisions)
  108. Contamination‏‎ (3 revisions)
  109. Exponential survival curve‏‎ (3 revisions)
  110. Unsealed source‏‎ (3 revisions)
  111. Xerostomia‏‎ (3 revisions)
  112. Annual limit on intake‏‎ (3 revisions)
  113. Dose per content function‏‎ (3 revisions)
  114. Interphase death‏‎ (3 revisions)
  115. Equity‏‎ (3 revisions)
  116. Test‏‎ (3 revisions)
  117. Graded approach‏‎ (3 revisions)
  118. Public exposure‏‎ (3 revisions)
  119. Fractionation‏‎ (3 revisions)
  120. Uptake‏‎ (3 revisions)
  121. Active (red) bone marrow‏‎ (3 revisions)
  122. Utilitarian ethics‏‎ (3 revisions)
  123. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  124. Operational quantity‏‎ (3 revisions)
  125. Value judgement‏‎ (3 revisions)
  126. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  127. Coster-Kronig transition‏‎ (3 revisions)
  128. Emergency preparedness‏‎ (3 revisions)
  129. Valvular heart disease‏‎ (3 revisions)
  130. Gray‏‎ (3 revisions)
  131. Personal dose equivalent‏‎ (3 revisions)
  132. Principle of justification‏‎ (3 revisions)
  133. Radiofrequency ablation‏‎ (3 revisions)
  134. Iso-effect plots‏‎ (3 revisions)
  135. Emergency procedures‏‎ (3 revisions)
  136. Lifetime risk estimates‏‎ (3 revisions)
  137. Absolute risk‏‎ (3 revisions)
  138. Virtue ethics‏‎ (3 revisions)
  139. Auger transition‏‎ (3 revisions)
  140. Bystander effect‏‎ (3 revisions)
  141. Derived air concentration‏‎ (3 revisions)
  142. Dignity‏‎ (3 revisions)
  143. Isomers‏‎ (3 revisions)
  144. Employer‏‎ (3 revisions)
  145. Activity median thermodynamic diameter‏‎ (3 revisions)
  146. Voxel phantom‏‎ (3 revisions)
  147. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  148. Complex tissues‏‎ (3 revisions)
  149. Growth fraction‏‎ (3 revisions)
  150. Organ dose equivalent‏‎ (3 revisions)
  151. Excretion rate (instantaneous)‏‎ (3 revisions)
  152. Extrathoracic airways‏‎ (3 revisions)
  153. Galactic cosmic radiation‏‎ (3 revisions)
  154. Growth hormone (somatotropin)‏‎ (3 revisions)
  155. ICRP Publication 103‏‎ (3 revisions)
  156. Spread-out Bragg peak‏‎ (3 revisions)
  157. Fairness‏‎ (3 revisions)
  158. Absorption‏‎ (3 revisions)
  159. Gamma ray‏‎ (3 revisions)
  160. Recovery‏‎ (3 revisions)
  161. DNA damage signalling‏‎ (3 revisions)
  162. Retrievability‏‎ (2 revisions)
  163. Immune system‏‎ (2 revisions)
  164. Institutional control‏‎ (2 revisions)
  165. Stakeholder‏‎ (2 revisions)
  166. Environmental radiation protection‏‎ (2 revisions)
  167. Tachycardia‏‎ (2 revisions)
  168. Exemption level‏‎ (2 revisions)
  169. Tissue equivalent material‏‎ (2 revisions)
  170. Myocardial stress test‏‎ (2 revisions)
  171. Oversight‏‎ (2 revisions)
  172. Projected dose‏‎ (2 revisions)
  173. Co-expertise‏‎ (2 revisions)
  174. Radionuclides of natural origin‏‎ (2 revisions)
  175. Connective tissue‏‎ (2 revisions)
  176. Recovery (cellular or tissue)‏‎ (2 revisions)
  177. DRL process‏‎ (2 revisions)
  178. Reversibility‏‎ (2 revisions)
  179. In vivo radiobioassay‏‎ (2 revisions)
  180. Solar particle event‏‎ (2 revisions)
  181. Effective dose equivalent‏‎ (2 revisions)
  182. Existing exposure situation‏‎ (2 revisions)
  183. Gastroschisis‏‎ (2 revisions)
  184. Worker‏‎ (2 revisions)
  185. Nuclear track detectors‏‎ (2 revisions)
  186. Angiogenesis‏‎ (2 revisions)
  187. Hyperbaric oxygen‏‎ (2 revisions)
  188. Bioturbation‏‎ (2 revisions)
  189. Cardioverter-defibrillator‏‎ (2 revisions)
  190. Radiation safety officer‏‎ (2 revisions)
  191. Radioresponsiveness‏‎ (2 revisions)
  192. Consequential late effects‏‎ (2 revisions)
  193. Recovery responder‏‎ (2 revisions)
  194. Rehabilitation of living conditions‏‎ (2 revisions)
  195. Right to know‏‎ (2 revisions)
  196. Incidence‏‎ (2 revisions)
  197. Solar wind‏‎ (2 revisions)
  198. Epithelium‏‎ (2 revisions)
  199. Target tissue‏‎ (2 revisions)
  200. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  201. Acceptance test‏‎ (2 revisions)
  202. Gastrulation‏‎ (2 revisions)
  203. Working level‏‎ (2 revisions)
  204. OLINDA/EXM‏‎ (2 revisions)
  205. Habitual mouth breather‏‎ (2 revisions)
  206. Annihilation photons‏‎ (2 revisions)
  207. Particle radiance‏‎ (2 revisions)
  208. Hyperfractionation‏‎ (2 revisions)
  209. Bone marrow‏‎ (2 revisions)
  210. Protection strategy‏‎ (2 revisions)
  211. Radiation source‏‎ (2 revisions)
  212. Cohort study‏‎ (2 revisions)
  213. Radiosensitiser‏‎ (2 revisions)
  214. DRL value‏‎ (2 revisions)
  215. Rigidity‏‎ (2 revisions)
  216. Dose-length product‏‎ (2 revisions)
  217. Security‏‎ (2 revisions)
  218. Incident‏‎ (2 revisions)
  219. Intermediate level waste‏‎ (2 revisions)
  220. Stenosis‏‎ (2 revisions)
  221. Equieffective dose‏‎ (2 revisions)
  222. Local DRL‏‎ (2 revisions)
  223. Expanded and aligned radiation field‏‎ (2 revisions)
  224. Tolerability‏‎ (2 revisions)
  225. Medical exposure‏‎ (2 revisions)
  226. Naturally occurring radioactive material‏‎ (2 revisions)
  227. Adventitious‏‎ (2 revisions)
  228. Working level month‏‎ (2 revisions)
  229. Habitual nose breather‏‎ (2 revisions)
  230. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  231. Background dose (rate)‏‎ (2 revisions)
  232. Radiosensitivity, cellular‏‎ (2 revisions)
  233. Containment‏‎ (2 revisions)
  234. Detriment‏‎ (2 revisions)
  235. Dose-rate effect‏‎ (2 revisions)
  236. Inclusiveness‏‎ (2 revisions)
  237. Source-related‏‎ (2 revisions)
  238. Internal conversion electron‏‎ (2 revisions)
  239. Electron-capture decay‏‎ (2 revisions)
  240. LD 50/30‏‎ (2 revisions)
  241. Telangiectasia‏‎ (2 revisions)
  242. Member of the public‏‎ (2 revisions)
  243. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  244. Unattached fraction‏‎ (2 revisions)
  245. Necrosis‏‎ (2 revisions)
  246. Patient entrance reference point‏‎ (2 revisions)
  247. Hypoplasia‏‎ (2 revisions)
  248. Backscatter detection system‏‎ (2 revisions)
  249. Potential recoverability correction factor‏‎ (2 revisions)
  250. Bradycardia‏‎ (2 revisions)
  251. Protective action guide‏‎ (2 revisions)
  252. Radiation worker‏‎ (2 revisions)
  253. Decay constant‏‎ (2 revisions)
  254. Self-help protection‏‎ (2 revisions)
  255. Individual-related‏‎ (2 revisions)
  256. Dose of record Hp (10)‏‎ (2 revisions)
  257. Electrophysiology‏‎ (2 revisions)
  258. Storage‏‎ (2 revisions)
  259. Track structure‏‎ (2 revisions)
  260. Mendelian diseases‏‎ (2 revisions)
  261. Accreditation‏‎ (2 revisions)
  262. Neurological syndrome‏‎ (2 revisions)
  263. Genomic integrity‏‎ (2 revisions)
  264. Occupational exposure‏‎ (2 revisions)
  265. Hazard‏‎ (2 revisions)
  266. Peak skin dose‏‎ (2 revisions)
  267. Bragg peak‏‎ (2 revisions)
  268. Radioactive dispersion device‏‎ (2 revisions)
  269. Radon: Units of Measure‏‎ (2 revisions)
  270. Coronary heart disease‏‎ (2 revisions)
  271. Reference air kerma‏‎ (2 revisions)
  272. Decommissioning‏‎ (2 revisions)
  273. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  274. Dose-threshold‏‎ (2 revisions)
  275. Individual decontamination‏‎ (2 revisions)
  276. Subcutaneous tissue‏‎ (2 revisions)
  277. Low dose rate‏‎ (2 revisions)
  278. Transfer compartment‏‎ (2 revisions)
  279. Mitigation‏‎ (2 revisions)
  280. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  281. Action Level‏‎ (2 revisions)
  282. Upper reference levels‏‎ (2 revisions)
  283. Neurovascular syndrome‏‎ (2 revisions)
  284. Health Surveillance‏‎ (2 revisions)
  285. Pelagic‏‎ (2 revisions)
  286. Basal cell‏‎ (2 revisions)
  287. Practical radiological protection culture‏‎ (2 revisions)
  288. Branching fraction‏‎ (2 revisions)
  289. Chronic exposure‏‎ (2 revisions)
  290. Radioactive source‏‎ (2 revisions)
  291. Colony‏‎ (2 revisions)
  292. Cosmic Radiation in Aviation‏‎ (2 revisions)
  293. Decontamination‏‎ (2 revisions)
  294. Relocation‏‎ (2 revisions)
  295. Diastasis‏‎ (2 revisions)
  296. Risk coefficient‏‎ (2 revisions)
  297. Individual monitoring‏‎ (2 revisions)
  298. Dose per unit intake coefficient‏‎ (2 revisions)
  299. Source term‏‎ (2 revisions)
  300. Emergency‏‎ (2 revisions)
  301. Latent time/period or latency interval‏‎ (2 revisions)
  302. Low level waste‏‎ (2 revisions)
  303. Exposure, external or internal‏‎ (2 revisions)
  304. Graft vs host disease‏‎ (2 revisions)
  305. Air-kerma, incident‏‎ (2 revisions)
  306. Heliosphere‏‎ (2 revisions)
  307. Qualified expert‏‎ (2 revisions)
  308. Class SR-0 gases‏‎ (2 revisions)
  309. Radioactive substance‏‎ (2 revisions)
  310. Reference biokinetic model‏‎ (2 revisions)
  311. Decontamination factor‏‎ (2 revisions)
  312. Remedial action‏‎ (2 revisions)
  313. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  314. Dose rate‏‎ (2 revisions)
  315. Intervention Level‏‎ (2 revisions)
  316. Emergency exposure situation‏‎ (2 revisions)
  317. Substantial radiation dose level‏‎ (2 revisions)
  318. Erythropoietin‏‎ (2 revisions)
  319. Exposure (in the context of inhalation)‏‎ (2 revisions)
  320. Transfer rate‏‎ (2 revisions)
  321. Multi-detector computed tomography‏‎ (2 revisions)
  322. Fractionation and dose delivery patterns‏‎ (2 revisions)
  323. Percutaneous coronary intervention‏‎ (2 revisions)
  324. Prevailing circumstances‏‎ (2 revisions)
  325. Broad beam therapy irradiation technique‏‎ (2 revisions)
  326. Class SR-1 gases‏‎ (2 revisions)
  327. Committed effective dose‏‎ (2 revisions)
  328. Radon Recommendations for Authorities‏‎ (2 revisions)
  329. Cost-benefit analysis‏‎ (2 revisions)
  330. Reference individual‏‎ (2 revisions)
  331. Remediation‏‎ (2 revisions)
  332. Dichotomous‏‎ (2 revisions)
  333. Risk of Exposure to Radon‏‎ (2 revisions)
  334. Dose rate effectiveness factor‏‎ (2 revisions)
  335. South Atlantic anomaly‏‎ (2 revisions)
  336. Interventional procedure‏‎ (2 revisions)
  337. Emergency plan‏‎ (2 revisions)
  338. Ethics‏‎ (2 revisions)
  339. Lymphatic system‏‎ (2 revisions)
  340. ALARA‏‎ (2 revisions)
  341. Transforming growth factor‏‎ (2 revisions)
  342. Hierarchical tissues‏‎ (2 revisions)
  343. Area monitoring‏‎ (2 revisions)
  344. Pericarditis‏‎ (2 revisions)
  345. Benthic‏‎ (2 revisions)
  346. Principle of application of dose limits‏‎ (2 revisions)
  347. Bronchial region‏‎ (2 revisions)
  348. Class SR-2 gases‏‎ (2 revisions)
  349. Radioactivity‏‎ (2 revisions)
  350. Committed equivalent dose‏‎ (2 revisions)
  351. Radon Recommendations for Workplaces‏‎ (2 revisions)
  352. Reference level‏‎ (2 revisions)
  353. Deontological Ethics‏‎ (2 revisions)
  354. Repopulation‏‎ (2 revisions)
  355. Differentiation‏‎ (2 revisions)
  356. Routine monitoring‏‎ (2 revisions)
  357. ICRPædia Guide to Radon‏‎ (2 revisions)
  358. Special (non-routine) monitoring‏‎ (2 revisions)
  359. Lifetime risk‏‎ (2 revisions)
  360. Macrophage colony stimulating factor‏‎ (2 revisions)
  361. Multiplicative risk projection model‏‎ (2 revisions)
  362. Activity‏‎ (2 revisions)
  363. High level waste‏‎ (2 revisions)
  364. Clearance‏‎ (2 revisions)
  365. Representative organism (non-human biota)‏‎ (2 revisions)
  366. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  367. Dose constraint‏‎ (2 revisions)
  368. Early normal tissue responses‏‎ (2 revisions)
  369. Threshold dose for tissue reactions‏‎ (2 revisions)
  370. Magnetosphere‏‎ (2 revisions)
  371. Beta-minus decay‏‎ (2 revisions)
  372. Clearance level‏‎ (2 revisions)
  373. Radiographer‏‎ (2 revisions)
  374. Representative person‏‎ (2 revisions)
  375. Safety‏‎ (2 revisions)
  376. Dose conversion coefficient‏‎ (2 revisions)
  377. Edema‏‎ (2 revisions)
  378. Specific effective energy‏‎ (2 revisions)
  379. Limitation of dose‏‎ (2 revisions)
  380. Excess relative risk‏‎ (2 revisions)
  381. Exposure situation‏‎ (2 revisions)
  382. Transmission detection system‏‎ (2 revisions)
  383. Multistage tumorigenesis‏‎ (2 revisions)
  384. Non-sphericity parameter‏‎ (2 revisions)
  385. Growth factor‏‎ (2 revisions)
  386. Alimentary tract transfer factor‏‎ (2 revisions)
  387. Pharynx‏‎ (2 revisions)
  388. Beta-plus decay‏‎ (2 revisions)
  389. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  390. Cumulative dose‏‎ (2 revisions)
  391. Reproductive integrity‏‎ (2 revisions)
  392. Safety case‏‎ (2 revisions)
  393. Slow repair‏‎ (2 revisions)
  394. Effect Dose 50‏‎ (2 revisions)
  395. Isotropic geometry‏‎ (2 revisions)
  396. Endogeneous excretion‏‎ (2 revisions)
  397. Lineal energy‏‎ (2 revisions)
  398. Thyroid blocking‏‎ (2 revisions)
  399. Exposure to Radon at Home‏‎ (2 revisions)
  400. Transparency‏‎ (2 revisions)
  401. GATA binding protein 2‏‎ (2 revisions)
  402. Waste disposal‏‎ (2 revisions)
  403. Non-targeted effects‏‎ (2 revisions)
  404. Hormones‏‎ (2 revisions)
  405. Authorization‏‎ (2 revisions)
  406. Procedural values‏‎ (2 revisions)
  407. Clonogenic cells‏‎ (2 revisions)
  408. Curie‏‎ (2 revisions)
  409. Residual dose‏‎ (2 revisions)
  410. Safety culture‏‎ (2 revisions)
  411. Solar cosmic radiation‏‎ (2 revisions)
  412. Inhalability‏‎ (2 revisions)
  413. Spontaneous fission‏‎ (2 revisions)
  414. Itinerant (radiation) worker‏‎ (2 revisions)
  415. Linear-non-threshold model‏‎ (2 revisions)
  416. Trapped particles‏‎ (2 revisions)
  417. Acute radiation syndrome‏‎ (2 revisions)
  418. Orphan source‏‎ (2 revisions)
  419. Hounsfield unit‏‎ (2 revisions)
  420. Authorized limit‏‎ (2 revisions)
  421. Planned exposure situation‏‎ (2 revisions)
  422. Progenitor cell‏‎ (2 revisions)
  423. Cardiac arrhythmias‏‎ (2 revisions)
  424. Radiation belt‏‎ (2 revisions - redirect page)
  425. Clonogenic survival‏‎ (2 revisions)
  426. Reasonableness‏‎ (2 revisions)
  427. Cytokines‏‎ (2 revisions)
  428. Respiratory protection‏‎ (2 revisions)
  429. Disposal‏‎ (2 revisions)
  430. Scintigraphy‏‎ (2 revisions)
  431. Dose criteria‏‎ (2 revisions)
  432. Solar cycle‏‎ (2 revisions)
  433. Inner bremsstrahlung‏‎ (2 revisions)
  434. Environmental exposure‏‎ (2 revisions)
  435. Systemic model‏‎ (2 revisions)
  436. Linear-quadratic dose response model‏‎ (2 revisions)
  437. Exempt waste‏‎ (2 revisions)
  438. Time factor‏‎ (2 revisions)
  439. Myocardial perfusion‏‎ (2 revisions)
  440. Adaptive response‏‎ (2 revisions)
  441. What is Radon?‏‎ (2 revisions)
  442. Alveolar-interstitial region‏‎ (2 revisions)
  443. Autoimmune disease‏‎ (2 revisions)
  444. Platelet-derived growth factor‏‎ (2 revisions)
  445. ICRP Publication 118‏‎ (2 revisions)
  446. Cardiac valve diseases‏‎ (2 revisions)
  447. Radiation modifier‏‎ (2 revisions)
  448. Radiological protection principles‏‎ (2 revisions)
  449. Regional diagnostic reference levels‏‎ (1 revision)
  450. ICRP Publication 30 (Supplement B to Part 3)‏‎ (1 revision)
  451. Derived reference level‏‎ (1 revision)
  452. ICRP Publication 95‏‎ (1 revision)
  453. ICRP Publication 43‏‎ (1 revision)
  454. Disposal facility‏‎ (1 revision)
  455. Sealed source‏‎ (1 revision)
  456. ICRP Publication 58‏‎ (1 revision)
  457. Solar flare‏‎ (1 revision)
  458. ICRP Publication 72‏‎ (1 revision)
  459. ICRP Publication 87‏‎ (1 revision)
  460. Linear dose response‏‎ (1 revision)
  461. Mean glandular dose‏‎ (1 revision)
  462. Absorption Type‏‎ (1 revision - redirect page)
  463. Trophic level‏‎ (1 revision)
  464. Additional dose‏‎ (1 revision)
  465. Nuclear medicine‏‎ (1 revision)
  466. Ambient dose equivalent‏‎ (1 revision)
  467. Human Respiratory Tract Model‏‎ (1 revision)
  468. Automatic exposure control‏‎ (1 revision)
  469. Pooled analysis‏‎ (1 revision)
  470. ICRP Publication 105‏‎ (1 revision)
  471. ICRP Publication 119‏‎ (1 revision)
  472. Radiation risk‏‎ (1 revision)
  473. ICRP Publication 133‏‎ (1 revision)
  474. ICRP Publication 148‏‎ (1 revision)
  475. ICRP Publication 22‏‎ (1 revision)
  476. Registry‏‎ (1 revision)
  477. ICRP Publication 30 (Supplement to Part 1)‏‎ (1 revision)
  478. Designated area‏‎ (1 revision)
  479. ICRP Publication 96‏‎ (1 revision)
  480. ICRP Publication 44‏‎ (1 revision)
  481. Distribution coefficient‏‎ (1 revision)
  482. Secondary radiation‏‎ (1 revision)
  483. ICRP Publication 59‏‎ (1 revision)
  484. Intake‏‎ (1 revision)
  485. ICRP Publication 73‏‎ (1 revision)
  486. Standard-size adult‏‎ (1 revision)
  487. ICRP Publication 88‏‎ (1 revision)
  488. Epigenetic effects‏‎ (1 revision)
  489. 1928 Recommendations‏‎ (1 revision)
  490. Tissue reaction‏‎ (1 revision)
  491. Measured quantity‏‎ (1 revision)
  492. Tumour suppressor gene‏‎ (1 revision)
  493. National DRL‏‎ (1 revision)
  494. Additive risk projection model‏‎ (1 revision)
  495. Oxygen enhancement ratio‏‎ (1 revision)
  496. Population risk‏‎ (1 revision)
  497. ICRP Publication 106‏‎ (1 revision)
  498. ICRP Publication 12‏‎ (1 revision)
  499. ICRP Publication 134‏‎ (1 revision)
  500. Cobblestone area forming cell assay‏‎ (1 revision)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)